Tonight, low temperatures are back into the mid to upper 30s. Dewpoint temperatures are on the rise now that winds have ...

Supporting Dewpoint’s novel condensate modulating approach to drug previously ‘undruggable’ therapeutic targets, guided by ...

On the 5th of November of this year, I awakened to another email from an organization of which I have been a member for almost its entire existence, the National Native American Boarding School ...

BEHIND THE FRONT Behind yesterday’s cold front, high pressure is building into the area, yielding drier air. UP AND DOWN ...

Dewpoint Therapeutics Inc. and Mitsubishi Tanabe Pharma Corp. have entered a research collaboration worth up to $480 million ...

The weather over the next ten days (Dec. 6-15) will be less like the smooth ride of a 1981 Lincoln Town Car and more like the ...

Dewpoint Therapeutics CEO Ameet Nathwani stated: “This partnership underscores the transformative potential of our small ...

As part of the deal, Dewpoint can expect an undisclosed upfront payment from Mitsubishi Tanabe Pharma Corporation (MTPC) in ...

Privately-held Dewpoint Therapeutics, a Boston, USA, biotech developing therapeutics by targeting biomolecular condensates, ...

Mitsubishi Tanabe Pharma is offering Dewpoint Therapeutics up to $480 million biobucks in a new research pact centering ...

The collaboration is another vote of confidence in Dewpoint’s biomolecular condensates research, which had already attracted ...